Parnax Lab (BOM:506128) 3-Year EBITDA Growth Rate : 37.90% (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Parnax Lab 3-Year EBITDA Growth Rate?

Parnax Lab's EBITDA per Share for the three months ended in Dec. 2023 was ₹5.30.

During the past 12 months, Parnax Lab's average EBITDA Per Share Growth Rate was -23.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 37.90% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 15.00% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 5.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Parnax Lab was 139.20% per year. The lowest was -19.30% per year. And the median was 10.35% per year.

Competitive Comparison of Parnax Lab's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Parnax Lab's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Parnax Lab's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Parnax Lab's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Parnax Lab's 3-Year EBITDA Growth Rate falls into.

Parnax Lab 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Parnax Lab (BOM:506128) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Parnax Lab 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Parnax Lab's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Parnax Lab (BOM:506128) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Parnax Lab Ltd (BOM:506128) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

104 - 107, Building No. 8, Gala No. 114, Jogani Industrial Complex, Panchsheel Nagar, Next to Modi Hyundai Service Centre, Chunabhatti, Sion, Mumbai, MH, IND, 400 022

Website

https://www.naxparlab.com

Parnax Lab Ltd is principally engaged in the manufacturing and export of Pharmaceutical Formulations. Its product categories include Pharmaceuticals; Cosmetics; Herbal and Nutraceuticals. The company is developing and delivering Oral Formulations such as Cough Expectorants, Antacids, Anti-Histamines, Multi-Vitamins, Enzyme Preparations, Pediatric Formulations, Special Formulations for Geriatrics, Highly Viscous Products, Suspensions, and others.

Parnax Lab (BOM:506128) Headlines

No Headlines